Clinical Trial Update: A Study to Further Assess Safety and Effectiveness Data of the Bortezomib(Velcade)/Melphalan/Prednisone (BMP) Regimen in Previously Untreated and Transplant Ineligible Multiple Myeloma Patients

View source ↗

Summary

This entry updates a clinical trial evaluating the BMP regimen (bortezomib, melphalan, prednisone) for previously untreated, transplant-ineligible multiple myel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Melphalan (Melphalan)
• PREDNISONE (Prednisone)
• Velcade (bortezomib)

Snippet

Sponsor: Janssen-Ortho Inc., Canada | Conditions: Multiple Myeloma | Status: NO_LONGER_AVAILABLE